The role of nutritional support in non-small-cell lung cancer treatment

Abstract

Scientific discoveries from recent years, along with rapid progress in clinical nutrition, are gradually changing the views of physicians around the world regarding the role of nutritional support in the treatment of patients with cancer. Nutritional support in the modern context is considered not only as part of basic care but also as a serious therapeutic tool in the treatment and rehabilitation of patients with cancer. The effectiveness of additional substrate provision in reducing the number of complications during specific treatment, as well as the ability of nutritional therapy to improve patients’ quality of life, has been proven.

The present review is devoted to the problem of nutritional supplementation in patients with non-small-cell lung cancer.

According to the current international clinical guidelines, the primary treatment for non-small-cell lung cancer is surgery, included as part of combination treatment, which aggravates nutritional status disorders. Against the background of metabolic disorders characteristic of the malignant process, anorexia-cachexia syndrome develops, accompanied by weight loss, which is extremely difficult to reverse. The metabolic response caused by surgical injury significantly accelerates catabolic processes and blocks anabolic ones, sharply increasing the patient's need for macronutrients and especially for protein, which, in the absence of exogenous intake, is “extracted” from muscle tissue. For the assimilation of this protein, an energy supply (carbohydrates and fats) is necessary, most of which is also derived from the patient's own tissues. With progressive weight loss in the preoperative period, protein and fat reserves in the postoperative period are not sufficient.

The relationship between malnutrition and adverse treatment outcomes dictates the need for routine determination of nutritional status and correction of existing disorders in all patients with lung cancer. Nevertheless, most clinicians pay insufficient attention to the problem of nutritional status disorders in patients with non-small-cell lung cancer.

To describe the necessity and safety of nutritional therapy in patients with non-small-cell lung cancer, an analysis of publications on the topic was carried out with a preliminary search in the medical databases PubMed and Medline. The data obtained show convincingly that patients with non-small-cell lung cancer often have anorexia-cachexia syndrome. In the perioperative period, nutritional support for non-small-cell lung cancer improves the immediate and long-term results of surgical treatment.

Currently, nutritional therapy should be considered as an integral component of any anticancer treatment, as it contributes to the improvement of therapeutic results.

Keywords

lung cancer / malnutrition / nutritional support / enteral nutrition

References

[1] Estimated number of new cases of lung cancer in 2020, worldwide, both sexes, all ages. GLOBOCAN 2020. International Agency for Research on Cancer; 2020.

[2] Estimated number of new cases of lung cancer in 2020, worldwide, both sexes, all ages. GLOBOCAN 2020. International Agency for Research on Cancer, 2020.

[3] Ettinger DS, Wood DE, et al. NCCN guidelines insights: non-small cell lung cancer, Version 2. J Natl Compr Canc Netw. 2021;19(3):254–266. doi: 10.6004/jnccn.2021.0013

[4] Ettinger D.S., Wood D.E., Aisner D.L., et al. NCCN guidelines insights: non-small cell lung cancer, Version 2 // J Natl Compr Canc Netw. 2021. Vol. 19, N 3. Р. 254–266. doi: 10.6004/jnccn.2021.0013

[5] Gorbunova VA, Marenich AF, Pchelin YY. Progress in drug treatment of non-small cell lung cancer. Russ Oncol J. 2007;(1): 51–54. (In Russ).

[6] Горбунова В.А., Маренич А.Ф., Пчелин Ю.Ю. Прогресс в лекарственном лечении немелкоклеточного рака легкого // Российский онкологический журнал. 2007. № 1. С. 51–54.

[7] Navani N, Piro SG. Chapter 5. Symptoms and signs of lung cancer. In: Spiro SG, Huber RM, Janes SM, editors. Thoracic malignancies. ERS Journal Ltd, 2009. Р. 71–87. doi: 10.1183/1025448x.00044005

[8] Navani N., Piro S.G. Chapter 5. Symptoms and signs of lung cancer. In: Spiro S.G., Huber R.M., Janes S.M., editors. Thoracic malignancies. ERS Journal Ltd, 2009. Р. 71–87. doi: 10.1183/1025448x.00044005

[9] Davydov MI, Gantsev SK. Oncology: textbook. Chapter 17. Moscow: GEOTAR-Media; 2010. 417 р. (In Russ).

[10] Давыдов М.И., Ганцев Ш.Х. Онкология: учебник. Гл. 17. Москва: ГЭОТАР-Медиа, 2010. 417 с.

[11] Kiss NK, Krishnasamy M, Isenring EA. The effect of nutrition intervention in lung cancer patients undergoing chemotherapy and/or radiotherapy: a systematic review. Nutr Cancer. 2014;66(1): 47–56. doi: 10.1080/01635581.2014.847966

[12] Kiss N.K., Krishnasamy M., Isenring E.A. The effect of nutrition intervention in lung cancer patients undergoing chemotherapy and/or radiotherapy: a systematic review // Nutr Cancer. 2014. Vol. 66, N 1. Р. 47–56. doi: 10.1080/01635581.2014.847966

[13] Baracos VE. Cancer-associated malnutrition. Eur J Clin Nutr. 2018;72(9):1255–1259. doi: 10.1038/s41430-018-0245-4

[14] Baracos V.E. Cancer-associated malnutrition // Eur J Clin Nutr. 2018. Vol. 72, N 9. Р. 1255–1259. doi: 10.1038/s41430-018-0245-4

[15] Allakhverdiev AK, Artamonova EV, Bagrova SG, et al. Lung cancer: clinical guidelines. Moscow; 2018. 51 р. (In Russ).

[16] Аллахвердиев А.К., Артамонова Е.В., Багрова С.Г., и др. Рак лёгкого: клинические рекомендации. Москва, 2018. 51 с.

[17] Postmus PE, Kerr KM, Oudkerk M, et al. Early-stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO clinical practice guidelines. Ann Oncol. 2017;28(Suppl. 4):iv1–iv21. doi: 10.1093/annonc/mdx222

[18] Postmus P.E., Kerr K.M., Oudkerk M., et al. Early-stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO clinical practice guidelines // Ann Oncol. 2017. Vol. 28, Suppl. 4. Р. iv1–iv21. doi: 10.1093/annonc/mdx222

[19] Davydov MI, Gantsev SH. Atlas of Oncology. Moscow: Meditsinskoye informatsionnoye agentstvo; 2008. 416 p. (In Russ).

[20] Давыдов М.И., Ганцев Ш.Х. Атлас по онкологии. Москва: Медицинское информационное агентство, 2008. 416 с.

[21] Muscaritoli M, Lucia S, Farcomeni A, et al. Prevalence of malnutrition in patients at first medical oncology visit: the PreMiO study. Oncotarget. 2017;8(45):79884–79896. doi: 10.18632/oncotarget.20168

[22] Muscaritoli M., Lucia S., Farcomeni A., et al. Prevalence of malnutrition in patients at first medical oncology visit: the PreMiO study // Oncotarget. 2017. Vol. 8, N 45. Р. 79884–79896. doi: 10.18632/oncotarget.20168

[23] Campagna S, Gonella S, Sperlinga R, et al. Prevalence, severity, and self-reported characteristics of taste alterations in patients receiving chemotherapy. Oncol Nurs Forum. 2018;45(3): 342–353. doi: 10.1188/18.ONF.342-353

[24] Campagna S., Gonella S., Sperlinga R., et al. Prevalence, severity, and self-reported characteristics of taste alterations in patients receiving chemotherapy // Oncol Nurs Forum. 2018. Vol. 45, N 3. Р. 342–353. doi: 10.1188/18.ONF.342-353

[25] Bozzetti F. Forcing the vicious circle: sarcopenia increases toxicity, decreases response to chemotherapy and worsens with chemotherapy. Ann Oncol. 2017;28(9):2107–2118. doi: 10.1093/annonc/mdx271

[26] Bozzetti F. Forcing the vicious circle: sarcopenia increases toxicity, decreases response to chemotherapy and worsens with chemotherapy // Ann Oncol. 2017. Vol. 28, N 9. Р. 2107–2118. doi: 10.1093/annonc/mdx271

[27] Nipp RD, Fuchs G, El-Jawahri A, et al. Sarcopenia is associated with quality of life and depression in patients with advanced cancer. Oncologist. 2018;23(1):97–104. doi: 10.1634/theoncologist.2017-0255

[28] Nipp R.D., Fuchs G., El-Jawahri A., et al. Sarcopenia is associated with quality of life and depression in patients with advanced cancer // Oncologist. 2018. Vol. 23, N 1. Р. 97–104. doi: 10.1634/theoncologist.2017-0255

[29] Marshall KM, Loeliger J, Nolte L, et al. Prevalence of malnutrition and impact on clinical outcomes in cancer services: a comparison of two time points. Clin Nutr. 2019;38(2):644–651. doi: 10.1016/j.clnu.2018.04.007

[30] Marshall K.M., Loeliger J., Nolte L., et al. Prevalence of malnutrition and impact on clinical outcomes in cancer services: A comparison of two time points // Clin Nutr. 2019. Vol. 38, N 2. Р. 644–651. doi: 10.1016/j.clnu.2018.04.007

[31] Shachar SS, Williams GR, Muss HB, Nishijima TF. Prognostic value of sarcopenia in adults with solid tumours: a meta-analysis and systematic review. Eur J Cancer. 2016;57:58–67. doi: 10.1016/j.ejca.2015.12.030

[32] Shachar S.S., Williams G.R., Muss H.B., Nishijima T.F. Prognostic value of sarcopenia in adults with solid tumours: a meta-analysis and systematic review // Eur J Cancer. 2016. Vol. 57. Р. 58–67. doi: 10.1016/j.ejca.2015.12.030

[33] Morel H, Raynard B, d’Arlhac M, et al. Prediagnosis weight loss, a stronger factor than BMI, to predict survival in patients with lung cancer. Lung Cancer. 2018;126:55–63. doi: 10.1016/j.lungcan.2018.07.005

[34] Morel H., Raynard B., d’Arlhac M., et al. Prediagnosis weight loss, a stronger factor than BMI, to predict survival in patients with lung cancer // Lung Cancer. 2018. Vol. 126. Р. 55–63. doi: 10.1016/j.lungcan.2018.07.005

[35] Batchelor TJ, Rasburn NJ, Abdelnour-Berchtold E, et al. Guidelines for enhanced recovery after lung surgery: recommendations of the Enhanced Recovery After Surgery (ERAS). Society and the European Society of Thoracic Surgeons (ESTS). Eur J Cardiothorac Surg. 2019;55(1):91–115. doi: 10.1093/ejcts/ezy301

[36] Batchelor T.J., Rasburn N.J., Abdelnour-Berchtold E., et al. Guidelines for enhanced recovery after lung surgery: recommendations of the Enhanced Recovery After Surgery (ERAS). Society and the European Society of Thoracic Surgeons (ESTS) // Eur J Cardiothorac Surg. 2019. Vol. 55, N 1. P. 91–115. doi: 10.1093/ejcts/ezy301

[37] Sytov AV, Zuzov SA, Kukosh MY, et al. Practical recommendations on nutritional support for cancer patients. Malignant Tumors. 2021;11(3s2-2):114–122. (In Russ). doi: 10.18027/2224-5057-2021-11-3s2-43

[38] Сытов А.В., Зузов С.А., Кукош М.Ю., и др. Практические рекомендации по нутритивной поддержке онкологических больных // Злокачественные опухоли. 2021. Т. 11, № 3s2-2. С. 114–122. doi: 10.18027/2224-5057-2021-11-3s2-43

[39] Khoronenko VE, Sergienko AD, Mandryka EA, et al. Assessment of nutritional status in cancer patients. Difficult Patient. 2018;16(5): 22–26. (In Russ).

[40] Хороненко В.Э., Сергиенко А.Д., Мандрыка Е.А., и др. Оценка нутритивного статуса у онкологических больных // Трудный пациент. 2018. Т. 16, № 5. С. 22–26.

[41] Obukhova OA, Snegovoy AV, Kurmukov IA, et al. Nutritional status of cancer patients before antitumor treatment: a single-center prospective observational study. Clin Nutrition Metabolism. 2020;1(4):178–189. (In Russ). doi: 10.17816/clinutr64707

[42] Обухова О.А., Снеговой А.В., Курмуков И.А., и др. Состояние питательного статуса онкологических больных перед проведением противоопухолевого лечения: одноцентровое проспективное наблюдательное исследование // Клиническое питание и метаболизм. 2020. Т. 1, № 4. С. 178–189. doi: 10.17816/clinutr64707

[43] Yang J, Zhang Q, Wang X. Role of nutritional support for postoperative recovery of respiratory function in patients with primary lung cancer. Oncol Lett. 2018;16(5):5978–5982. doi: 10.3892/ol.2018.9348

[44] Yang J., Zhang Q., Wang X. Role of nutritional support for postoperative recovery of respiratory function in patients with primary lung cancer // Oncol Lett. 2018. Vol. 16, N 5. P. 5978–5982. doi: 10.3892/ol.2018.9348

[45] Kaya SO, Akcam TI, Ceylan KC, et al. Is preoperative protein-rich nutrition effective on postoperative outcome in non-small cell lung cancer surgery? A prospective randomized study. J Cardiothorac Surg. 2016;11:14. doi: 10.1186/s13019-016-0407-1

[46] Kaya S.O., Akcam T.I., Ceylan K.C., et al. Is preoperative protein-rich nutrition effective on postoperative outcome in non-small cell lung cancer surgery? A prospective randomized study // J Cardiothorac Surg. 2016. Vol. 11. P. 14. doi: 10.1186/s13019-016-0407-1

[47] Ding Q, Chen W, et al. Accelerated rehabilitation combined with enteral nutrition in the management of lung cancer surgery patients. Asia Pac J Clin Nutr. 2020;29(2):274–279. doi: 10.6133/apjcn.202007_29(2).0010

[48] Ding Q., Chen W., Gu Y., et al. Accelerated rehabilitation combined with enteral nutrition in the management of lung cancer surgery patients // Asia Pac J Clin Nutr. 2020. Vol. 29, N 2. Р. 274–279. doi: 10.6133/apjcn.202007_29(2).0010

[49] Lee SC, SH, et al. Prediction of postoperative pulmonary complications using preoperative controlling nutritional status (CONUT) score in patients with resectable non-small cell lung cancer. 2020;10(1):12385. doi:

[50] Lee S.C., Lee J.G., Lee S.H., et al. Prediction of postoperative pulmonary complications using preoperative controlling nutritional status (CONUT) score in patients with resectable non-small cell lung cancer // Sci Rep. 2020. Vol. 10, N 1. Р. 12385. doi: 10.1038/s41598-020-68929-9

[51] Gul B, et al. The relationship between nutritional status and prognosis in patients with locally advanced and advanced stage lung cancer. Support Care Cancer. 2021;29(6):3357–3365. doi:

[52] Gul B., Metintas S., Ak G., et al. The relationship between nutritional status and prognosis in patients with locally advanced and advanced stage lung cancer // Support Care Cancer. 2021. Vol. 29, N 6. Р. 3357–3365. doi: 10.1007/s00520-020-05856-5

[53] Obukhova OA, Kurmukov IA, Yunaev GS. The role of nutritional support in the treatment of malignant neoplasms of the liver. Clin Nutr Metabolism. 2020;1(3):117–126. (In Russ). doi: 10.17816/clinutr54419

[54] Обухова О.А., Курмуков И.А., Юнаев Г.С. Роль питательной поддержки при лечении злокачественных новообразований печени // Клиническое питание и метаболизм. 2020. Т. 1, № 3. C. 117–126. doi: 10.17816/clinutr54419

[55] Muscaritoli M, Arends J, Bachmann P, et al. ESPEN practical guideline: Clinical Nutrition in cancer. Clin Nutr. 2021;40(5): 2898–2913. doi: 10.1016/j.clnu.2021.02.005

[56] Muscaritoli M., Arends J., Bachmann P., et al. ESPEN practical guideline: Clinical Nutrition in cancer // Clin Nutr. 2021. Vol. 40, N 5. Р. 2898–2913. doi: 10.1016/j.clnu.2021.02.005

[57] Arends J, Strasser F, Gonella S, et al. Cancer cachexia in adult patients: ESMO Clinical Practice Guidelines. ESMO Open. 2021;6(3):100092. doi: 10.1016/j.esmoop.2021.100092

[58] Arends J., Strasser F., Gonella S., et al. Cancer cachexia in adult patients: ESMO Clinical Practice Guidelines // ESMO Open. 2021. Vol. 6, N 3. Р. 100092. doi: 10.1016/j.esmoop.2021.100092

[59] Khomyakov VM, Yermoshina AD. Correction of nutritional insufficiency in cancer patients using ready-made mixtures for oral nutrition (siping). Res Practice Med. 2015;2(3):82–88. (In Russ). doi: 10.17709/2409-2231-2015-2-3-82-88

[60] Хомяков В.М., Ермошина А.Д. Коррекция нутритивной недостаточности у онкологических больных с использованием готовых смесей для перорального питания (сипинга) // Исследования и практика в медицине. 2015. Т. 2, № 3. С. 82–88. doi: 10.17709/2409-2231-2015-2-3-82-88

[61] De Haan J, Renken RJ, Moshage Y, et al. Self-reported taste and smell alterations and the liking of oral nutritional supplements with sensory-adapted flavors in cancer patients receiving systemic antitumor treatment. Support Care Cancer. 2021;29(10):5691–5699. doi: 10.1007/s00520-021-06049-4

[62] De Haan J., Renken R.J., Moshage Y., et al. Self-reported taste and smell alterations and the liking of oral nutritional supplements with sensory-adapted flavors in cancer patients receiving systemic antitumor treatment // Support Care Cancer. 2021. Vol. 29, N 10. Р. 5691–5699. doi: 10.1007/s00520-021-06049-4

RIGHTS & PERMISSIONS

Kononets P.V., Obukhova O.A., Sergienko A.D.